The Prognostic Utility of Anticholinergic Burden Scales: An Integrative Review and Gap Analysis.
Henry Ukachukwu MichaelOkechukwu EnechukwuMarie-Josée BrouilletteRobyn TamblynLesley K FellowsNancy E MayoPublished in: Drugs & aging (2023)
Future research recommendations to bridge knowledge gaps include developing a risk assessment framework, refining ABS scales, establishing a standardized consensus scale, and creating a longitudinal measure of cumulative anticholinergic risk. Strategies to minimize bias, consider frailty, and promote multidisciplinary and multinational collaborations are also necessary to improve patient outcomes.